Taiwan Advance Bio-Pharmaceutical Inc. (TPEX:4186)

Taiwan · Delayed Price · Currency is TWD

10.20

+0.05 (0.49%)

Mar 25, 2026, 10:25 AM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Precise Medical Division	240.94M	200.91M	188.42M	130.03M	130.98M
Precise Medical Division Growth	19.92%	6.63%	44.90%	-0.72%	22.88%
Food Safety Business Division	30.63M	39.19M	51.88M	50.40M	47.25M
Food Safety Business Division Growth	-21.84%	-24.47%	2.94%	6.67%	-
Inspection Business Division	82.61M	75.89M	77.94M	62.94M	57.35M
Inspection Business Division Growth	8.86%	-2.63%	23.84%	9.74%	12.96%
Total	354.17M	315.98M	318.24M	243.36M	235.57M
Total Growth	12.09%	-0.71%	30.77%	3.31%	14.47%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Asia	354.17M	315.98M	317.62M	243.36M	235.16M
Asia Growth	12.09%	-0.51%	30.51%	3.49%	14.36%
America	-	-	618.00K	-	18.00K
America Growth	-	-	-	-	5.88%
Europe	-	-	-	-	399.00K
Europe Growth	-	-	-	-	146.30%
Total	354.17M	315.98M	318.24M	243.36M	235.57M
Total Growth	12.09%	-0.71%	30.77%	3.31%	14.47%

Source: S&P Global Market Intelligence.